Halozyme Therapeutics shares owned by Advantage Alpha Capital Partners
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Advantage Alpha Capital Partners
from 13F filings
Historical chart of Advantage Alpha Capital Partners investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Advantage Alpha Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Advantage Alpha Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $621k | 8.5k | 73.34 |
| 2025-06-30 | $522k | 10k | 52.02 |
| 2025-03-31 | $883k | 14k | 63.81 |
| 2024-12-31 | $432k | 9.0k | 47.81 |
| 2024-09-30 | $844k | 15k | 57.24 |
| 2024-06-30 | $1.3M | 25k | 52.36 |
| 2024-03-31 | $1.1M | 27k | 40.68 |
More positions owned by Advantage Alpha Capital Partners
View all positions for Advantage Alpha Capital Partners